AR and hepatocellular carcinoma: Given that some lncRNAs have been proven much more specific than other biomarker in cancer (Soares et al., 2019), it remains unknown whether a prognostic model composed of multiple AR-lncRNAs could act more efficiently than the current known prognostic signatures for HCC.